Breaking News on Global Pharmaceutical Technology & Manufacturing

Glenmark selects Cyndea to make gel capsule drugs

19-Jul-2017 - Cyndea Pharma and Glenmark Pharmaceuticals have partnered to make generic soft-gelatin capsule products for multiple markets.

Pfizer hires Catalent to make smaller format Advil using Optigel tech

18-Jul-2017 - Pfizer Inc. has awarded Catalent Pharma Solutions the long-term manufacturing contract for a smaller version of its over-the-counter (OTC) painkiller Advil (ibuprofen). 

Elite halts trials of reformulated SequestOx after BE data falls short

10-Jul-2017 - Elite Pharmaceuticals has halted trials of its reformulated opioid painkiller SequestOx (naltrexone and oxycodone hydrochloride) after disappointing bioequivalence data from a study testing the drug in combination with a high fat meal.

Nanoparticle delivery tech targets rare lung disease

10-Jul-2017 - Researchers at London, UK-based Imperial College are developing a technology to transport drugs directly to the lungs of pulmonary arterial hypertension (PAH) patients.

Pump up the volume: Cellnovo adding insulin device line in Romania

04-Jul-2017 - French technology firm Cellnovo has selected Flex Ltd to build a production line in Romania, to manufacture insulin cartridges for its diabetes management system.

Microneedle patch stable, painless and simple say researchers

29-Jun-2017 - The team behind a microneedle patch designed to administer influenza vaccines say it has increased thermostability compared to needle and syringe immunisation methods.

Opiant has new Narcan nasal spray patent listed in US FDA orange book

29-Jun-2017 - Opiant Pharmaceuticals says it has strengthened its IP position for the emergency opioid overdose treatment Narcan nasal spray.

Pfizer starts work on Missouri biotherapeutics R&D hub

28-Jun-2017 - Pfizer is building a $200m (€179m) R&D centre in Chesterfield, Missouri at which it will consolidate biotherapeutics process development operations in the region.

Lonza’s $5.5bn Capsugel takeover cleared by regulators

27-Jun-2017 - Lonza expects to complete its $5.5bn (€5.2bn) takeover of Capsugel SA in the next few days having secured approval from competition authorities around the world.

News in brief

Zynerba starts Ph I study of cannabinoid pain patch

26-Jun-2017 - Zynerba Pharmaceuticals Inc has begun a Phase I trial of cannabinoid patch it is developing for fibromyalgia and peripheral neuropathic pain.

Adamis has not set US price for newly approved rival to Mylan's $600 EpiPen

19-Jun-2017 - The US FDA has approved Symjepi, a rival to Mylan’s emergency anaphylaxis treatment EpiPen made by Adamis Pharmaceuticals Corporation.

US FDA lifts hold on Inovio's cancer vaccine trials after firm answers device questions

15-Jun-2017 - Inovio Pharmaceuticals has started Phase III trials of its DNA-based human papillomavirus therapy VGX-3100 after the US FDA lifted a clinical hold imposed list year.

News in brief

Lubrizol invests $60m in drug production at Particle Science plant

12-Jun-2017 - The Lubrizol Corporation has invested $60m (€53m) in its Particle Science drug manufacturing business.

'Talking' smart pill looks to overhaul prescription opioid space and stop abuse

08-Jun-2017 - Pop Test Abuse Deterrent Technologies has received a patent for an opioid drug delivery and abuse deterrent ‘smart pill’ it says can prevent death, theft, diversion and counterfeiting.

Takeda breaks ground on $45m Ninlaro plant in Ireland

06-Jun-2017 - Takeda has begun construction of an Irish facility to support production of its orally delivered blood cancer peptide Ninlaro (ixazomib).

Vetter inks ‘pain-free’ needle deal to meet alternative drug delivery demand

05-Jun-2017 - Vetter Pharma has signed a strategic agreement to develop Microdermics’ microneedle drug delivery technology.

Rho to support NDA for Evoke Pharma’s patented nasal spray

01-Jun-2017 - Rho has been contracted to support Evoke Pharma’s planned NDA submission for its nasal delivery formulation of metoclopramide, Gimoti.

Cure Pharma’s API delivery tech on the tip of the tongue

30-May-2017 - Cure Pharmaceutical has submitted a patent application for an oral film delivery technology it says can combine several active pharmaceutical ingredients without negative interaction. 

Long-acting insulin price concerns challenge WHO proposal

30-May-2017 - Non-profit organisations have challenged the proposed addition of long-acting insulin analogues to the World Health Organisation’s Model List of Essential Medicines, citing price as a key factor.

Eye drops to replace painful injections in AMD patients

24-May-2017 - The University of Birmingham has developed a cell-penetrating peptide it claims could be used to make eye drop versions of age-related macular degeneration drugs currently delivered by injection.

Synlogic takeover secures Mirna’s NASDAQ listing + $40m cash

22-May-2017 - Synlogic has announced it will conduct a reverse merger with failed Mirna Therapeutics, to focus on metabolic and inflammatory diseases and cancer.

Aduro and Merck & Co to test Keytruda and CRS-207 in second cancer study

22-May-2017 - Merck & Co and Aduro Biotech have announced plans to test Keytruda combined with CRS-207 in patients suffering malignant pleural mesothelioma as a result of exposure to asbestos.

Consolidated vaccine sector urgently needs a workforce booster shot, Sanofi

16-May-2017 - Long life-cycles and significant consolidation in the manufacturing space have led to a lack of skilled workers in the vaccine space, says Sanofi Pasteur.

News in brief

Thermo Fisher Scientific Inc to buy Patheon NV for $7.2bn

15-May-2017 - Thermo Fisher Scientific Inc has announced its intention to buy Patheon NV in a deal agreed by both firms’ boards.

Aptar Pharma continues its North American expansion

11-May-2017 - Aptar Pharma has acquired 20% of the US-based company, Kali Care, less than two months after inaugurating its first facility outside of France as it aims to expand globally. 

Key Industry Events


Access all events listing

Our events, Shows & Conferences...